MOLECULE DETAILS: STATUS: Modified ISO 1750 (provisionally approved) IUPAC NAME: methyl (2RS,4RS)-4-({[(5S)-3-(3,5-difluorophenyl)-5-vinyl-4,5-dihydroisoxazol-5-yl]carbonyl}amino)tetrahydrofuran-2-carboxylate containing 40–70% of the (2R,4R)-isomer and 60–30% of the (2S,4S)-isomer…
UK
-
-
Active Agrochemical IngredientAgrochemical Discovery Candidates (New ISO)Icafolin
BAYER CROP SCIENCE HERBICIDE CANDIDATE – ICAFOLIN – GOT ISO STATUS-1750
by adminby adminIcafolin is a herbicide, which is highly effective against economically important harmful plants even at relatively low application rates and can be…
-
Active Agrochemical IngredientAgrochemical Discovery Candidates (New ISO)Pyraquinate
NEW ISO HERBICIDE CANDIDATE 2023 – PYRAQUINATE – BY SHANDONG CYNDA CHEMICAL CO., LTD., CHINA IN HERBICIDE CLASS
by adminby adminPyraquinate is a herbicide containing the quinazolinone compound and provides a novel HPPD-based inhibitor which has excellent control effects on weeds in…
-
CompaniesMerger / AcquisitionNovartis
Sandoz Acquires Drug Delivery Device Firm Coalesce
by adminby adminSummary : Sandoz acquired the capabilities and assets of drug delivery device company, Coalesce, to further its existing portfolio of respiratory medicines…
-
EuropePharma Science & Research
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
by adminby adminSummary : NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with…
-
Global Market
Syniverse Is First to Offer a Cloud-Native, Hyperscale Digital Communications and Messaging Platform for Enterprises: Syniverse’s Hyperscale Communications Platform
by adminby adminSummary : New Syniverse CPaaS Platform to Accelerate Enterprises’ Digital Transformation and Improve Customer Experience The Syniverse Hyperscale Communications Platform allows enterprises…
-
Pharma Science & Research
Research Collab Uncovers Underlying Mechanism for ALS and Dementia
by adminby adminSummary : For years, researchers interested in treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have struggled to understand why variants…
-
Global Market
Lysogene Provides Update on Efficacy, Safety and Timelines of the AAVance Phase 2/3 Clinical Trial with Gene Therapy LYS-SAF302 for the Treatment of MPSIIIA
by adminby adminSummary : Topline data of the main cohort of AAVance clinical trial expected in Q3 2022 Stabilization or decreased size of white…
-
Pharma Science & Research
Alexion and UK patient advocacy groups launch video campaign
by adminby adminSummary : Rare Disease Day has inspired a pioneering video to support patients living with rare conditions Alexion Pharma UK has launched…
-
Global Market
VivoPower International PLC’s Kenshaw Critical Power Business Expands to New Headquarters
by adminby adminSummary : VivoPower International PLC (NASDAQ: VVPR) (“VivoPower,” the “Company”) is pleased to announce that its wholly-owned subsidiary in Australia, Kenshaw Electrical…